![Ulrich Grau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulrich Grau
Directeur/Bestuurslid bij
Vermogen: 594 $ op 31-05-2025
Profiel
Ulrich M.
Grau is the founder of Lux Biosciences, Inc. which was founded in 2006.
He held the title of President & Chief Executive Officer from 2006 to 2010.
Currently, Dr. Grau is the Director at Thermosome GmbH and a Member-Supervisory Board at Affimed GmbH since 2015.
In his former positions, he was the Director at Large Scale Biology Corp.
from 2005 to 2008, Chief Scientific Officer at Enzon Pharmaceuticals, Inc. from 2002 to 2005, and Senior VP-Global Late Stage Development at Sanofi India Ltd. He also served as Senior Vice President at Hoechst Marion Roussel Ltd. (United Kingdom) from 1997 to 1999, President-Research & Development at BASF Pharma Ltd. from 2000 to 2001, Chief Operating Officer & Executive Vice President at Amgen Rockville, Inc. from 2011 to 2012, and held the position of Senior VP-Global Late Stage Development at Aventis Pharma AG.
Additionally, Dr. Grau is an Independent Member-Supervisory Board at Affimed NV from 2015 to 2024.
He obtained a doctorate degree from Universität Stuttgart.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AFFIMED N.V. 0,13% | 15-03-2024 | 20.000 ( 0,13% ) | 594 $ | 31-05-2025 |
Actieve functies van Ulrich Grau
| Bedrijven | Functie | Begin |
|---|---|---|
Thermosome GmbH
 Thermosome GmbH Pharmaceuticals: MajorHealth Technology Thermosome GmbH develops novel drugs for solid tumors. Its technology is used for delivery of various active pharmaceutical ingredients with its application in localized diseases. The company was founded by Lars Lindner, Martin Hossan and Hansjoerg Eibl and is headquartered in Planegg, Germany. | Directeur/Bestuurslid | - |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Directeur/Bestuurslid | 01-07-2015 |
Eerdere bekende functies van Ulrich Grau
| Bedrijven | Functie | Einde |
|---|---|---|
| AFFIMED N.V. | Directeur/Bestuurslid | 26-06-2024 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Operationeel Directeur | 01-01-2012 |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Algemeen Directeur | 01-01-2010 |
Large Scale Biology Corp.
 Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Directeur/Bestuurslid | 18-08-2008 |
| ENZON PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 |
Opleiding van Ulrich Grau
Universität Stuttgart | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| AFFIMED N.V. | Health Technology |
| SANOFI INDIA LIMITED | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Large Scale Biology Corp.
Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Health Technology |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Hoechst Marion Roussel Ltd. (United Kingdom)
 Hoechst Marion Roussel Ltd. (United Kingdom) Pharmaceuticals: OtherHealth Technology Founded in 1994, Hoechst Marion Roussel Ltd. (United Kingdom) is a British pharmaceutical company that manufactures pharmaceutical products. Part of Sanofi, the company is based in Guildford, UK. | Health Technology |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Health Technology |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Thermosome GmbH
Thermosome GmbH Pharmaceuticals: MajorHealth Technology Thermosome GmbH develops novel drugs for solid tumors. Its technology is used for delivery of various active pharmaceutical ingredients with its application in localized diseases. The company was founded by Lars Lindner, Martin Hossan and Hansjoerg Eibl and is headquartered in Planegg, Germany. | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
Aventis Pharma AG |
